-
公开(公告)号:US07153858B2
公开(公告)日:2006-12-26
申请号:US10768579
申请日:2004-01-30
申请人: Dale S. Dhanoa , Dongli Chen , Oren Becker , Silvia Noiman , Srinivasa Rao Cheruku , Yael Marantz , Anurag Sharadendu , Sharon Shachem , Alexander Heifetz , Pradyumna Mohanty , Boaz Inbal , Merav Fichman , Raphael Nudelman , Shay Bar-Haim
发明人: Dale S. Dhanoa , Dongli Chen , Oren Becker , Silvia Noiman , Srinivasa Rao Cheruku , Yael Marantz , Anurag Sharadendu , Sharon Shachem , Alexander Heifetz , Pradyumna Mohanty , Boaz Inbal , Merav Fichman , Raphael Nudelman , Shay Bar-Haim
IPC分类号: A61K31/495 , A61K31/496 , C07D295/13 , C07D401/06 , A61K31/506 , C07D403/04
CPC分类号: C07D213/74 , C07D211/96 , C07D239/42 , C07D295/13 , C07D401/12
摘要: The invention relates to 5-HT receptor agonists or antagonists. Novel arylpiperazinyl sulfonamide compounds represented by Formulae I: and II, and synthesis and uses of those compounds for treating diseases including those mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include central nervous system disorders such as generalized anxiety disorder, ADD/ADHD, neural injury, stroke, and migraine. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.
摘要翻译: 本发明涉及5-HT受体激动剂或拮抗剂。 公开了由式I和II表示的新型芳基哌嗪基磺酰胺化合物,以及用于治疗包括由5-HT受体直接或间接介导的那些疾病的那些化合物的合成和用途。 这些病症包括中枢神经系统疾病,如广泛性焦虑症,ADD / ADHD,神经损伤,中风和偏头痛。 还包括制备方法和新型中间体及其药物盐。
-
公开(公告)号:US20070004742A1
公开(公告)日:2007-01-04
申请号:US11516345
申请日:2006-09-05
申请人: Dale Dhanoa , Dongli Chen , Oren Becker , Silvia Noiman , Srinivasa Cheruku , Yael Marantz , Anurag Sharadendu , Sharon Shachem , Alexander Heifetz , Pradyumna Mohanty , Boaz Inbal , Merav Fichman , Raphael Nudelman , Shay Bar-Haim
发明人: Dale Dhanoa , Dongli Chen , Oren Becker , Silvia Noiman , Srinivasa Cheruku , Yael Marantz , Anurag Sharadendu , Sharon Shachem , Alexander Heifetz , Pradyumna Mohanty , Boaz Inbal , Merav Fichman , Raphael Nudelman , Shay Bar-Haim
IPC分类号: A61K31/497 , A61K31/496 , A61K31/506 , C07D403/02 , A61K31/4965 , C07D241/02
CPC分类号: C07D213/74 , C07D211/96 , C07D239/42 , C07D295/13 , C07D401/12
摘要: The invention relates to 5-HT receptor agonists or antagonists. Novel arylpiperazinyl sulfonamide compounds represented by Formula I, and synthesis and uses thereof for treating diseases including those mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include central nervous system disorders such as generalized anxiety disorder, ADD/ADHD, neural injury, stroke, and migraine. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.
摘要翻译: 本发明涉及5-HT受体激动剂或拮抗剂。 公开了由式I表示的新型芳基哌嗪基磺酰胺化合物及其用于治疗包括由5-HT受体直接或间接介导的疾病的疾病的合成和用途。 这些病症包括中枢神经系统疾病,如广泛性焦虑症,ADD / ADHD,神经损伤,中风和偏头痛。 还包括制备方法和新型中间体及其药物盐。
-
公开(公告)号:US07030240B2
公开(公告)日:2006-04-18
申请号:US10815417
申请日:2004-03-31
申请人: Dale S. Dhanoa , Oren Becker , Silvia Noiman , Sekar A. Reddy , Srinivasa Rao Cheruku , Rosa E. Mele'ndez , Anurag Sharadendu , Dongli Chen , Yael Marantz , Sharon Shachem , Alexander Heifetz , Boaz Inbal , Venkitasamy Kesavan , Shay Bar-Haim
发明人: Dale S. Dhanoa , Oren Becker , Silvia Noiman , Sekar A. Reddy , Srinivasa Rao Cheruku , Rosa E. Mele'ndez , Anurag Sharadendu , Dongli Chen , Yael Marantz , Sharon Shachem , Alexander Heifetz , Boaz Inbal , Venkitasamy Kesavan , Shay Bar-Haim
IPC分类号: C07D495/04
CPC分类号: C07D495/04
摘要: The invention relates to 5-HT receptor antagonists. Novel piperidinylamino-thieno[2,3-d] pyrimidine compounds represented by Formula I, and synthesis and uses thereof for treating diseases mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include central nervous system disorders such as anxiety, depression, schizophrenia, neural injury, stroke, and migraine. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.
摘要翻译: 本发明涉及5-HT受体拮抗剂。 公开了由式I表示的新型哌啶基氨基 - 噻吩并[2,3-d]嘧啶化合物及其用于治疗由5-HT受体直接或间接介导的疾病的合成和用途。 这些病症包括焦虑,抑郁,精神分裂症,神经损伤,中风和偏头痛等中枢神经系统疾病。 还包括制备方法和新型中间体及其药物盐。
-
-